Phase II trial of the oral PARP inhibitor olaparib in BRCA-deficient advanced breast cancer Meeting Abstract


Authors: Tutt, A.; Robson, M.; Garber, J. E.; Domchek, S.; Audeh, M. W.; Weitzel, J. N.; Friedlander, M.; Carmichael, J.
Abstract Title: Phase II trial of the oral PARP inhibitor olaparib in BRCA-deficient advanced breast cancer
Meeting Title: 45th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 27
Issue: 18 Suppl.
Meeting Dates: 2009 May 29-Jun 2
Meeting Location: Orlando, FL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2009-06-20
Start Page: 803s
Language: English
ACCESSION: WOS:000276607000010
PROVIDER: wos
DOI: 10.1200/jco.2009.27.18_suppl.cra501
Notes: Meeting Abstract: CRA501 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Mark E Robson
    676 Robson